FibroGen (FGEN) News Today

$0.62

0.00 (0.00%)

(As of 12/8/2023 ET)

Today's Range: $0.59
▼
$0.65
50-Day Range: $0.38
▼
$0.81
52-Week Range: $0.33
▼
$25.69

Volume: 774,248 shs
Average Volume: 1.88 million shs
Market Capitalization: $60.97 million

P/E Ratio: N/A
Dividend Yield: N/A
Price Target: $22.00

Source

Source	Headline
	FibroGen Presents Data from Phase 3 MATTERHORN Trial of Roxadustat in Patients with Anemia of Lower Risk Transfusion-Dependent Myelodysplastic Syndromes at American Society of Hematology Annual Meeting finance.yahoo.com - December 9 at 5:54 PM
	FibroGen (NASDAQ:FGEN) Coverage Initiated at StockNews.com americanbankingnews.com - December 8 at 1:20 AM
	FibroGen, Inc. (FGEN) stock price, news, quote & history – Yahoo Finance sg.finance.yahoo.com - December 4 at 9:31 AM
	FibroGen, Inc. (NASDAQ:FGEN) Receives Consensus Recommendation of "Reduce" from Analysts americanbankingnews.com - November 30 at 2:16 AM
	FibroGen (NASDAQ:FGEN) Now Covered by StockNews.com americanbankingnews.com - November 30 at 1:30 AM
	FibroGen Inc FGEN morningstar.com - November 11 at 3:35 PM
	FibroGen, Inc. (NASDAQ:FGEN) Q3 2023 Earnings Call Transcript finance.yahoo.com - November 7 at 3:51 PM
	FibroGen (FGEN) Q3 Earnings: Taking a Look at Key Metrics Versus Estimates finance.yahoo.com - November 6 at 9:43 PM
	FibroGen Inc (FGEN) Reports 155% YoY Increase in Q3 2023 Net Revenue finance.yahoo.com - November 6 at 9:43 PM
	FibroGen Reports Third Quarter 2023 Financial Results finance.yahoo.com - November 6 at 4:43 PM
	FibroGen earnings: here's what Wall Street expects markets.businessinsider.com - November 5 at 10:41 AM
	Bronstein, Gewirtz & Grossman, LLC Notifies Shareholders of Fibrogen, Inc. (FGEN) Investigation barrons.com - October 29 at 2:05 PM
	FibroGen to Report Third Quarter 2023 Financial Results finance.yahoo.com - October 23 at 9:28 AM
	FibroGen's Pamrevlumab Doesn't Meet Goals In Phase III LELANTOS-2 Trial; Stock Down In Pre-market markets.businessinsider.com - August 30 at 11:15 AM
	Three In A Row: FibroGen's Investigational Drug Flunks In Another Study For Rare Disease In Young Boys markets.businessinsider.com - August 30 at 11:15 AM
	FibroGen stock plummets as muscular dystrophy drug trial fails proactiveinvestors.com - August 30 at 11:15 AM
	FibroGen (NASDAQ: FGEN) Tumbles after Setback in Phase 3 DMD Trial msn.com - August 30 at 11:15 AM
	Stocks to Watch: FibroGen, Box marketwatch.com - August 29 at 11:12 PM
	FibroGen's drug misses mark on yet another clinical trial finance.yahoo.com - August 29 at 11:12 PM
	FibroGen Shares Sink 16% on Pamrevlumab Study Not Meeting Primary Endpoint marketwatch.com - August 29 at 6:11 PM
	FibroGen stock tumbles on failed Phase 3 study for muscular dystrophy drug msn.com - August 29 at 6:11 PM
	FibroGen Announces Topline Results from LELANTOS-2, a Phase 3 Clinical Study of Pamrevlumab in Ambulatory Duchenne Muscular Dystrophy finance.yahoo.com - August 29 at 6:11 PM
	FibroGen, Inc. (NASDAQ:FGEN) Receives Consensus Rating of "Reduce" from Analysts marketbeat.com - August 22 at 4:37 AM
	Down -46.88% in 4 Weeks, Here's Why FibroGen (FGEN) Looks Ripe for a Turnaround finance.yahoo.com - August 16 at 5:06 PM
	Q3 2023 Earnings Forecast for FibroGen, Inc. Issued By William Blair (NASDAQ:FGEN) marketbeat.com - August 10 at 7:44 AM
	Is There An Opportunity With FibroGen, Inc.'s (NASDAQ:FGEN) 42% Undervaluation? finance.yahoo.com - August 9 at 11:15 AM
	FibroGen Reports Second Quarter 2023 Financial Results finance.yahoo.com - August 9 at 12:49 AM
	B of A Securities Downgrades FibroGen (FGEN) msn.com - August 8 at 7:49 PM
	Expert Ratings for FibroGen markets.businessinsider.com - August 8 at 2:49 PM
	FibroGen Q2 2023 Earnings Preview seekingalpha.com - August 8 at 9:48 AM
	FibroGen (FGEN) Q2 Earnings: Taking a Look at Key Metrics Versus Estimates finance.yahoo.com - August 8 at 9:48 AM
	FibroGen, Inc. (NASDAQ:FGEN) Q2 2023 Earnings Call Transcript finance.yahoo.com - August 8 at 9:48 AM
	FibroGen (NASDAQ:FGEN) Downgraded to Underperform at Bank of America marketbeat.com - August 8 at 7:14 AM
	Jump Financial LLC Buys Shares of 54,174 FibroGen, Inc. (NASDAQ:FGEN) marketbeat.com - August 3 at 5:38 AM
	San FranciscoBusiness Times bizjournals.com - July 31 at 4:08 PM
	Intercontinental Wealth Advisors LLC Sells 95,650 Shares of FibroGen, Inc. (NASDAQ:FGEN) marketbeat.com - July 29 at 12:31 AM
	FibroGen, Inc. (NASDAQ:FGEN) Given Average Recommendation of "Reduce" by Brokerages marketbeat.com - July 28 at 3:49 AM
	FibroGen CEO resigns after back-to-back drug study failures, job cuts finance.yahoo.com - July 25 at 3:44 PM
	FibroGen, Inc.: FibroGen Announces Leadership Transition finanznachrichten.de - July 25 at 10:43 AM
	FibroGen Announces Leadership Transition finance.yahoo.com - July 25 at 10:43 AM
	FibroGen to Report Second Quarter 2023 Financial Results finance.yahoo.com - July 24 at 8:25 AM
	State of New Jersey Common Pension Fund D Sells 60,739 Shares of FibroGen, Inc. (NASDAQ:FGEN) marketbeat.com - July 23 at 4:33 AM
	SF biotech company FibroGen laying off nearly a third of its workers msn.com - July 20 at 8:49 AM
	Pioneering Mission Bay biotech company Fibrogen to cut more than 100 jobs bizjournals.com - July 19 at 12:27 PM
	FibroGen (FGEN) Forms 'Hammer Chart Pattern': Time for Bottom Fishing? finance.yahoo.com - July 14 at 1:07 PM
	Down -83.78% in 4 Weeks, Here's Why FibroGen (FGEN) Looks Ripe for a Turnaround finance.yahoo.com - July 11 at 3:36 PM
	Allspring Global Investments Holdings LLC Grows Stock Holdings in FibroGen, Inc. (NASDAQ:FGEN) marketbeat.com - July 10 at 4:20 AM
	FibroGen (FGEN) Price Target Decreased by 67.57% to 8.16 msn.com - July 6 at 3:32 PM
	Down 80% in 1 Day, Is There Any Hope for FibroGen Stock? finance.yahoo.com - July 1 at 9:10 AM
	1,344,583 Shares in FibroGen, Inc. (NASDAQ:FGEN) Bought by Assenagon Asset Management S.A. marketbeat.com - June 30 at 6:30 AM

Get FibroGen News Delivered to You Automatically

FGEN Media Mentions By Week

FGEN Media Sentiment

Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press.

FGEN
News Sentiment
▼
-0.37

0.52
▲
Average
Medical
News Sentiment

FGEN News Coverage

We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week.

FGEN Articles
This Week
▼
3

2
▲
FGEN Articles
Average Week

Get FibroGen News Delivered to You Automatically

Related Companies and Tools

Related Companies:

Headlines Tools:

This page (NASDAQ:FGEN) was last updated on 12/10/2023 by MarketBeat.com Staff

Get 30 Days of MarketBeat All Access Free

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your 30-Day Free Trial

FibroGen (FGEN) News Today

FGEN Media Mentions By Week

FGEN Media Sentiment

FGEN News Coverage

Related Companies and Tools

About MarketBeat

Popular Tools

Financial Calendars

Terms & Info